Q: I recently started a small position in guardant, in the past week or so, share price has dropped, should I increase my position,? Also, do you really like company for longer term growth, current weighting in my portfolio is 1%.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: GH price has had a rough week, any particular reason, and do you still like this company on a long term basis for growth, I have a small position and wondering if I should move on, or stick it out.
Q: Hello
Could you comment on CVS and AIG following recent earnings?
Regarding Amazons possible entry into Health market (online pharmacy I believe), has there been any recent news on that?
Thank you
Stephane
Could you comment on CVS and AIG following recent earnings?
Regarding Amazons possible entry into Health market (online pharmacy I believe), has there been any recent news on that?
Thank you
Stephane
Q: GUD is having a good day after Medison came out swinging on Friday. Can you explain why GUD is up today? Is there other news I'm missing?
Q: Medison came out with another negative statement after Knights earnings.
Is this just noise or does Medison have a game plan here.
Would like your thoughts on this.
Thanks John
Is this just noise or does Medison have a game plan here.
Would like your thoughts on this.
Thanks John
Q: Good morning,
VMD is down almost 15 % today. The only news I can see is that they just announced that they will have a listing on Nasdaq. Is it not generally positive news, when a stock is able to have more than one listing? It seems by the reaction that this is viewed negatively.
Thanks,
Jim
VMD is down almost 15 % today. The only news I can see is that they just announced that they will have a listing on Nasdaq. Is it not generally positive news, when a stock is able to have more than one listing? It seems by the reaction that this is viewed negatively.
Thanks,
Jim
Q: Could you discuss the implications of the recent news. Is this change the fundamentals significantly enough to warrant selling today?
Q: Hello 5I Team
What do you make of CTX these days. Positive numbers, buying back shares, patents approved in the us along with some drug sales. Does it look interesting yet? What are the downsides?
Thank You
Clarence
What do you make of CTX these days. Positive numbers, buying back shares, patents approved in the us along with some drug sales. Does it look interesting yet? What are the downsides?
Thank You
Clarence
Q: I have been following GH but did not start a position. Given the strong Q2 results and the momentum in the stock would you initiate a position now or wait for some market volatility?
Q: Good afternoon,
I know US listed stocks are not your focus just looking for an opinion on ZTS quarter numbers that were just reported. It looks good to me, I hold this in a TFSA well diversified. Would you add more to current position? My average cost currently is 94 per share, I am looking for long term capital growth. Thanks
I know US listed stocks are not your focus just looking for an opinion on ZTS quarter numbers that were just reported. It looks good to me, I hold this in a TFSA well diversified. Would you add more to current position? My average cost currently is 94 per share, I am looking for long term capital growth. Thanks
Q: Hi 5i
Would you suggest buying Pfizer today or wait to see what direction the stock price moves. I’m a very long term investor.
Thx
Gerry
Would you suggest buying Pfizer today or wait to see what direction the stock price moves. I’m a very long term investor.
Thx
Gerry
Q: Peter & Co., I am considering a position in NOVO for a 2-3 year hold. May I please have your analysis and recommendation?
With appreciation.
Ed
With appreciation.
Ed
Q: The Globe published this, "Scotiabank analyst Ben Isaacson initiated coverage of MediPharm Labs Corp. with a “sector outperform” rating and $17 target. The average is $7.35."
This seems extreme. Do you know what the analyst's logic was? (or was it a typo somewhere along the way?)
This seems extreme. Do you know what the analyst's logic was? (or was it a typo somewhere along the way?)
Q: I am looking to get some exposure to the health care sector and thought I would look at an ETF as opposed to a single company. I'm considering either XLV or IHI and would like your opinion of these two ETFs, and which you would prefer. I would be adding the ETF as a full position in my RRSP.
Also, if there is another ETF that you prefer over these two, please include that in your response.
thanks for your insight
Paula
Also, if there is another ETF that you prefer over these two, please include that in your response.
thanks for your insight
Paula
Q: Share price seems to be drifting downwards...any reason that you see why this is the case?
Thanks, Mike
Thanks, Mike
Q: What are your thoughts on Viemed as a new position? Why are you negative on a couple of their large shareholders? Is this company a strong takeover candidate? Thanks!
Q: What is your opinion of Smith & Nephew? I need some non-Canadian healthcare in my portfolio. Would this be a reasonable purchase or would you recommend an alternative?
-
Johnson & Johnson (JNJ)
-
Extendicare Inc. (EXE)
-
Medical Facilities Corporation (DR)
-
Sienna Senior Living Inc. (SIA)
Q: Hi Peter & Ryan, I’m very light in the healthcare sector after recently selling JNJ. I rely on dividends to supplement my pension income and was looking at DR:CA, EXE:CA and SIA:CA. Can you please comment on each of these, quality of the companies, management, safety of the dividend etc. Feel free to suggest other names not listed Canadian or US. Dividend payers preferred. ( I already hold csh.un and used to own sis). Thanks. Mario
Q: May I please have your opinion on the latest news today. Thank you.
Q: Hi Peter and Team
The US will be able to import drugs from Cdn firms. Which firms would likely benefit the most and by how much?
Thanks for your excellent advice.
The US will be able to import drugs from Cdn firms. Which firms would likely benefit the most and by how much?
Thanks for your excellent advice.